Chengdu Olymvax Biopharmaceuticals (SHSE:688319) Goodwill-to-Asset : 0.00 (As of Mar. 2025)

Chengdu Olymvax Biopharmaceuticals Goodwill-to-Asset Chart

Chengdu Olymvax Biopharmaceuticals Annual Data
	Trend	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
Goodwill-to-Asset		Get a 7-Day Free Trial					-	-	-	-	-

Chengdu Olymvax Biopharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Goodwill-to-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Chengdu Olymvax Biopharmaceuticals's Goodwill-to-Asset

For the Biotechnology subindustry, Chengdu Olymvax Biopharmaceuticals's Goodwill-to-Asset, along with its competitors' market caps and Goodwill-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chengdu Olymvax Biopharmaceuticals's Goodwill-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chengdu Olymvax Biopharmaceuticals's Goodwill-to-Asset distribution charts can be found below:

* The bar in red indicates where Chengdu Olymvax Biopharmaceuticals's Goodwill-to-Asset falls into.

Chengdu Olymvax Biopharmaceuticals Goodwill-to-Asset Calculation

Goodwill to Asset ratio measures how much goodwill a company is recording compared to the total level of its assets.

It is calculated by dividing goodwill by total assets.

Chengdu Olymvax Biopharmaceuticals's Goodwill to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Chengdu Olymvax Biopharmaceuticals's Goodwill to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chengdu Olymvax Biopharmaceuticals  (SHSE:688319) Goodwill-to-Asset Explanation

If the goodwill-to-asset ratio increases, it can mean that the company is recording a proportionately higher amount of goodwill, assuming total assets are remaining constant. It is generally good to see a company increasing its assets regularly; however, if these increases are coming from intangible assets, such as goodwill, the increases may not be as good.

Increases in the goodwill-to-asset ratio might suggest that a company has been aggressively acquiring other firms or has seen its tangible assets decrease in value. When a large portion of total assets are attributable to intangible assets (such as goodwill), the company may be at risk of having that portion of its asset base wiped out quickly if it must record any goodwill impairments. Decreases in the goodwill-to-assets ratio suggest that the company has either written down some goodwill or increased its tangible assets.

Asset needs vary from industry to industry. This is why comparing goodwill-to-assets ratios is generally most meaningful among companies within the same industry. By comparing a company's goodwill to assets ratio to those of other companies within the same industry, investors can get a feel for how a company is managing its goodwill.

Chengdu Olymvax Biopharmaceuticals Goodwill-to-Asset Related Terms

Thank you for viewing the detailed overview of Chengdu Olymvax Biopharmaceuticals's Goodwill-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Olymvax Biopharmaceuticals Business Description